- IGM Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- IGM Biosciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- IGM Biosciences Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- IGM Biosciences Inc Clinical Update Conference Call TranscriptJun 02, 2023
- IGM Biosciences Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- IGM Biosciences Inc at Stifel Targeted Oncology Days (Virtual) TranscriptApr 26, 2023
- Q4 2022 IGM Biosciences Inc Earnings Call TranscriptMar 30, 2023$17.02 (-1.45%)Earnings
- IGM Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- IGM Biosciences Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 08, 2022
- IGM Biosciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- IGM Biosciences Inc Annual Shareholders Meeting TranscriptJun 21, 2022
- IGM Biosciences Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2022
- IGM Biosciences Inc to Discuss Global Collaboration Agreement with Sanofi - Conference Call TranscriptMar 29, 2022
- IGM Biosciences Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) TranscriptFeb 10, 2022
- IGM Biosciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- IGM Biosciences Inc to Discuss IGMS ASH Data - Conference Call TranscriptDec 12, 2021
- IGM Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- IGM Biosciences Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 19, 2021
- IGM Biosciences Inc at Truist Securities Life Sciences Summit (May Series) TranscriptMay 04, 2021
- Q4 2020 IGM Biosciences Inc Earnings Call TranscriptMar 30, 2021$75.06 (+1.86%)Earnings
- IGM Biosciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Medivir AB to Discuss Exclusive Licensing Agreement with IGM Biosciences for Birinapant Call TranscriptJan 12, 2021
- IGM Biosciences Inc Review of IGM-2323 Data Presented at the 62nd Annual ASH Meeting - Conference Call TranscriptDec 05, 2020
- IGM Biosciences Inc at Wolfe Research Healthcare Conference (Virtual) TranscriptNov 18, 2020
- IGM Biosciences Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 17, 2020
- IGM Biosciences Inc at Stifel Virtual Healthcare Conference TranscriptNov 16, 2020
- IGM Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 18, 2020
- IGM Biosciences Inc Extraordinary Shareholders Meeting TranscriptJul 30, 2020
- IGM Biosciences Inc Annual Shareholders Meeting TranscriptJun 09, 2020
- Q4 2019 IGM Biosciences Inc Earnings Call TranscriptMar 26, 2020$43 (-9.11%)Earnings
- IGM Biosciences Inc at Barclays Global Healthcare Conference TranscriptMar 11, 2020
IGM Biosciences Inc Annual Shareholders Meeting Transcript
Good afternoon, and welcome to IGM Biosciences Inc.'s 2022 annual meeting of stockholders. Please note that this event is being webcast. I would now like to introduce Fred Schwarzer, the company's Chief Executive Officer, President, and Director. Mr. Schwarzer, please go ahead.
Welcome, everyone. Thank you for joining our 2022 annual meeting of stockholders. We are once again holding our annual stockholders meeting virtually this year to support the health and well-being of our shareholders, and to afford the same rights and opportunities to participate as would be available in an in-person meeting.
The principal purpose of this meeting is to seek stockholder approval of certain proposals. We will begin with the formal business portion during which we'll address the matters described in our 2022 proxy statement for which approval is sought, vote on these proposals, and announce preliminary voting results.
At this time, I'd like to introduce the other members of our Board of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)